Cargando…

Super enhancer associated RAI14 is a new potential biomarker in lung adenocarcinoma

PURPOSE: Tyrosine kinase inhibitors (TKIs) are widely used to treat lung adenocarcinoma patients with EGFR mutations or ALK-fusions. However, patients with wild-type genes or TKIs-resistant mutations lack effective therapeutic targets. Extensive studies reveal that super enhancer (SE), a large cis-r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Chongze, Hu, Hong, Kuang, Muyu, Chen, Zongwei, Tao, Xiaoting, Fang, Shengjian, Sun, Yihua, Zhang, Yawei, Chen, Haiquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739635/ https://www.ncbi.nlm.nih.gov/pubmed/29285248 http://dx.doi.org/10.18632/oncotarget.22165

Ejemplares similares

Clinical Significance of Complex Glandular Patterns in Lung Adenocarcinoma: Clinicopathologic and Molecular Study in a Large Series of Cases
por: Kuang, Muyu, et al.
Publicado: (2018)

Survival following segmentectomy or lobectomy in elderly patients with early-stage lung cancer
por: Zhang, Yang, et al.
Publicado: (2016)

Proteomic analysis of plasma exosomes to differentiate malignant from benign pulmonary nodules
por: Kuang, Muyu, et al.
Publicado: (2019)

A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks
por: Yuan, Chongze, et al.
Publicado: (2021)

Prognostic prediction of lung adenocarcinoma by integrative analysis of RHOH expression and methylation
por: Kuang, Muyu, et al.
Publicado: (2023)

Comparison of perioperative and survival outcomes between sublobar resection and lobectomy of patients who underwent a second pulmonary resection
por: Yao, Xingxin, et al.
Publicado: (2021)

Integrated analysis of optical mapping and whole-genome sequencing reveals intratumoral genetic heterogeneity in metastatic lung squamous cell carcinoma
por: Peng, Yizhou, et al.
Publicado: (2020)

RAI14 in the blood feather regulates chicken pigmentation
por: Adetula, Adeyinka Abiola, et al.
Publicado: (2020)

Knockdown of RAI14 suppresses the progression of gastric cancer
por: Chen, Cheng, et al.
Publicado: (2018)

Genomic alterations dissection revealed MUC4 mutation as a potential driver in lung adenocarcinoma local recurrence
por: Yuan, Chongze, et al.
Publicado: (2023)

RAI14 Is a Prognostic Biomarker and Correlated With Immune Cell Infiltrates in Gastric Cancer
por: Xiao, Yu, et al.
Publicado: (2020)

Retinoic Acid Induced Protein 14 (Rai14) is dispensable for mouse spermatogenesis
por: Wu, Yangyang, et al.
Publicado: (2021)

High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value
por: He, Xin-Yang, et al.
Publicado: (2018)

Genomic and immune profiling of pre-invasive lung adenocarcinoma
por: Chen, Haiquan, et al.
Publicado: (2019)

A propensity score matching analysis of survival following segmentectomy or wedge resection in early-stage lung invasive adenocarcinoma or squamous cell carcinoma
por: Zhang, Yang, et al.
Publicado: (2016)

Downregulation of RAI14 inhibits the proliferation and invasion of breast cancer cells
por: Gu, Ming, et al.
Publicado: (2019)

Rai14 is a novel interactor of Invariant chain that regulates macropinocytosis
por: Lobos Patorniti, Natacha, et al.
Publicado: (2023)

RAI14 Promotes Melanoma Progression by Regulating the FBXO32/c-MYC Pathway
por: Xu, Jie, et al.
Publicado: (2022)

RAI14 (retinoic acid induced protein 14) is an F-actin regulator: Lesson from the testis
por: Qian, Xiaojing, et al.
Publicado: (2013)

Rais[z]al /
por: Gómez Palacio y Gutiérrez Zamora, Ignacio
Publicado: (1990)

Abnormal Activations of Super-Enhancers Enhance the Carcinogenicity in Lung Adenocarcinoma
por: Zhou, Jianlong, et al.
Publicado: (2020)

RAI14 silencing suppresses progression of esophageal cancer via the STAT3 pathway
por: Wang, Jianlin, et al.
Publicado: (2020)

Radiologic Identification of Pathologic Tumor Invasion in Patients With Lung Adenocarcinoma
por: Ye, Ting, et al.
Publicado: (2023)

Spectrum of Oncogenic Driver Mutations in Lung Adenocarcinomas from East Asian Never Smokers
por: Li, Chenguang, et al.
Publicado: (2011)

Risk stratification in differentiated thyroid cancer with RAI-avid lung metastases
por: Ohkuwa, Keiko, et al.
Publicado: (2021)

Rai14 (Retinoic Acid Induced Protein 14) Is Involved in Regulating F-Actin Dynamics at the Ectoplasmic Specialization in the Rat Testis*
por: Qian, Xiaojing, et al.
Publicado: (2013)

Emission RAI 3: Zichichi Miratti
Publicado: (2004)

Dr. Yatendra Chandra Rai Vora
por: Gupta, Sunanda
Publicado: (2012)

The Late Rai Bahadur Hira Lal
Publicado: (1924)

Comprehensive analysis of the expression and prognosis for RAI2: A promising biomarker in breast cancer
por: Jiao, Ying, et al.
Publicado: (2023)

MET exon 14 skipping defines a unique molecular class of non-small cell lung cancer
por: Zheng, Difan, et al.
Publicado: (2016)

Effect of tumor size on prognosis of node-negative lung cancer with sufficient lymph node examination and no disease extension
por: Zhang, Yang, et al.
Publicado: (2016)

High expression of CXCL14 is a biomarker of lung adenocarcinoma with micropapillary pattern
por: Sata, Yuki, et al.
Publicado: (2020)

Comparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinoma
por: Cai, Deng, et al.
Publicado: (2014)

Chromobox 4 facilitates tumorigenesis of lung adenocarcinoma through the Wnt/β-catenin pathway
por: Wang, Zuoyun, et al.
Publicado: (2020)

The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma
por: Zhang, Yang, et al.
Publicado: (2014)

When Should (99m)Tc Bone Scintigraphy Be Performed in cT1N0 Non-Small Cell Lung Cancer Patients?
por: Li, Hang, et al.
Publicado: (2015)

La tragedia de Gilles de Rais
por: Bataille, Georges, 1897-1962
Publicado: (1972)

interRAI home care quality indicators
por: Morris, John N, et al.
Publicado: (2013)

The deubiquitinating enzyme STAMBP is a newly discovered driver of triple-negative breast cancer progression that maintains RAI14 protein stability
por: Yang, Qianqian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1rost20vriv2kj9uq2unmh4ild